| ²é¿´: 1451 | »Ø¸´: 4 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
Çó¸ßÊÖ°ïÎÒ·ÒëÕâÒ»¶Î£¬ÓкܶàרҵÊõÓÉúÃü¿ÆÑ§Õâ¿éµÄ³æ×ÓÓ¦¸ÃºÜÊìϤ
|
|||
|
Competitive ELISA for quantification of trastuzumab. Tissues from BT474 tumor mice that received trastuzumab injections were homogenized in 1 ml of 0.1 M Glycine pH2 with 1% Tween-20 and protease inhibitors followed by a centrifugation (4˚C, 10 min, 14,000 rpm). Six hundred microliters of supernatant was collected, and added with 150 ¦Ìl of 1 M Tris pH8 and 22.5 ¦Ìl of 5 M NaCl to neutralize the pH. Microtiter wells coated with 5 mg/ml rabbit anti-human IgG were incubated with the tissue extracts and 1 ¦Ìg/ml of biotinylated human IgG. After 2 hours of incubation at room temperature, the wells were washed with PBS containing 0.01% Tween 20, added with streptavidin-conjugated horseradish peroxidase, and incubated for 30 minutes at room temperature. The amount of biotinylated human IgG captured on the microtiter wells was quantified with 2,2-azino-bis(3-etylbenzthiazoline-6-sulfonic acid) as a substrate and the absorbance at 405 nm was measured. To obtain standard curves, the tissue extracts were substituted with various concentrations of trastuzumab (ranging from 0.01 to 10 ¦Ìg/ml) in the ELISA. |
» ²ÂÄãϲ»¶
filecode£¬4¸öjtjcÁË
ÒѾÓÐ17È˻ظ´
ºÅÍâºÅÍâ
ÒѾÓÐ5È˻ظ´
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ22È˻ظ´
ÈËÆø²»ÐÐÁË
ÒѾÓÐ9È˻ظ´
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ6È˻ظ´
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ5È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ19È˻ظ´
½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã
ÒѾÓÐ16È˻ظ´
½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û
ÒѾÓÐ21È˻ظ´
¹À¼ÆÊÇÖÜËÄ
ÒѾÓÐ4È˻ظ´
4Â¥2010-12-07 19:15:08
gary8812
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 58
- Ó¦Öú: 11 (СѧÉú)
- ¹ó±ö: 0.005
- ½ð±Ò: 9278
- Ìû×Ó: 1781
- ÔÚÏß: 1158.4Сʱ
- ³æºÅ: 607349
2Â¥2010-12-05 19:27:42
ringzhu
ľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 24
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ¹ó±ö: 1.318
- ½ð±Ò: 1370.6
- Ìû×Ó: 4511
- ÔÚÏß: 703.5Сʱ
- ³æºÅ: 825134
3Â¥2010-12-07 16:03:58
5Â¥2010-12-07 19:16:24









»Ø¸´´ËÂ¥
20